Genetic Signatures Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 3.6 million compared to AUD 10.41 million a year ago. Net loss was AUD 10.47 million compared to AUD 6.48 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.705 AUD | 0.00% | +3.68% | +62.07% |
Apr. 30 | Genetic Signatures Appoints Interim CEO | MT |
Apr. 28 | Genetic Signatures' Sales Drop in Fiscal Q3 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.07% | 86M | |
+7.62% | 218B | |
+6.70% | 183B | |
+11.94% | 134B | |
+24.60% | 106B | |
-2.66% | 61.12B | |
+4.81% | 50.89B | |
+11.55% | 51.26B | |
-1.09% | 40.3B | |
+26.82% | 32.05B |
- Stock Market
- Equities
- GSS Stock
- News Genetic Signatures Limited
- Genetic Signatures Limited Reports Earnings Results for the Half Year Ended December 31, 2023